Related Experiment Videos
[Transplantation from animal to man]
1Thoraxkirurgisk avdeling Rikshospitalet, Oslo. a.e.fiane@klinmed.uio.no
Summary
Xenotransplantation using transgenic pigs offers a potential solution to the organ shortage. Overcoming hyperacute rejection is a key step, but infectious agent risks require thorough investigation before clinical use.
Area of Science:
- Transplantation immunology
- Regenerative medicine
- Medical ethics
Background:
- Severe shortage of donor organs limits transplantation therapy.
- Xenotransplantation, particularly using transgenic pigs, is a promising alternative.
- Existing clinical trials focus on pig cells for diabetes and neurodegenerative disorders.
Purpose of the Study:
- To explore the potential of xenotransplantation to address organ scarcity.
- To review the progress in overcoming immunological barriers in xenotransplantation.
- To highlight the remaining challenges and necessary future research directions.
Main Methods:
- Review of current research in xenotransplantation, focusing on transgenic pig models.
- Analysis of immunological obstacles, specifically hyperacute rejection.
- Assessment of risks associated with infectious agents (retroviruses) in xenotransplantation.
Main Results:
- Hyperacute rejection, a major hurdle, is nearing resolution.
- Transgenic pig organs show potential for bridging or permanent transplantation.
- Ongoing clinical trials demonstrate feasibility for cell and tissue therapies.
Conclusions:
- Xenotransplantation holds significant promise for alleviating organ shortages.
- Further research is needed to refine immunosuppression and understand physiology.
- Rigorous investigation of infectious risks and establishment of ethical guidelines are crucial for safe clinical implementation.